News

FDA sets June decision deadline for potential full approval, label expansion of Sarepta’s Duchenne gene therapy

Sarepta Therapeutics could soon notch another regulatory win. Despite the company and its Duchenne gene therapy getting dogged by debate, and then a failed confirmatory study, the treatment appears headed for a label expansion that […]

News

Exscientia fires CEO Andrew Hopkins after alleged ‘inappropriate’ relationships with two employees

Exscientia’s board terminated CEO Andrew Hopkins over alleged relationships with two employees, effective immediately, per a Tuesday SEC filing. Chairman David Nicholson has also resigned, the UK biotech said, following an investigation that found he […]

News

CSL Announces Top-line Results from the Phase 3 AEGIS-II Trial Evaluating the Efficacy and Safety of CSL112 (apolipoprotein A-I [human])

KING OF PRUSSIA, Pa., Feb. 11, 2024 /PRNewswire/ — Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced top-line results from the Phase 3 AEGIS-II trial evaluating the efficacy and safety of CSL112 (apolipoprotein A-I [human]) […]